View efficacy data for Amgen’s products indicated in the treatment of cancer therapy complications, including:

• Aranesp® (darbepoetin alfa)— for more information, please visit Aranesp.com 
• Neulasta® (pegfilgrastim)— for treatment-associated neutropenia
• Kepivance® (palifermin)— for treatment of therapy-related oral mucositis